Article Date

According to the Irish Times, Irish investment in the US is at an all time high. For many of the Irish companies currently succeeding in the US, leveraging contacts made at home has been a critical factor in their growth.


Allan Schouten, PM Group’s US President spoke to the Irish Times about our journey and the recent investment in a Life Sciences Centre in Philadelphia.

“For PM Group it’s all about building relationships, building trust, and delivering on commitments. We are just one of a number of Irish firms that has grown off the back of US investments in Ireland over the past 40 years."

With offices in Boston and San Francisco established since 2010, PM Group recently opened a new office in Philadelphia, which the company sees as an integral part of its strategic plan to grow its US operations.

US headcount has doubled to 150 in the past year and expects that level of growth to continue. “It includes not just Irish colleagues who have moved to the US, and US colleagues who moved back, but the fact that the vast majority are US life science specialists,” Allan explains.

PM Group is recognised by US industry bible ENR (Engineering News-Record) as a Top Five Pharma Engineering design firm. Turnover in 2020 was $400 million and clients include AbbVie, Bayer, Johnson & Johnson, Merck, Regeneron, Resilience, Sanofi and Thermo Fisher Scientific.


Read the full article in the Irish Times